 |
 |
||||||
 |
Commentaires de nos clients |
Votre panier
€ 0.00 (0 articles)
| |||||
Générique Azelastine - Optivar
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth.
- Sildenafil citrate and pulmonary arterial hypertension
Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure.
- Fruit and vegetables do not reduce overall cancer risk, review concludes
Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people.
- Common painkillers could be linked to male reproductive disorder
The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study.
Notre page de facturation est certifiée par:
- New Combo Allergy Drug Approved by FDA - Medscape
New Combo Allergy Drug Approved by FDAMedscapeDymista (Meda Pharmaceuticals) nasal spray combines fluticasone propionate (Flonase, GlaxoSmithKline) and azelastine hydrochloride (Astepro, Astelin, Meda Pharmaceuticals).
- FDA approves Meda allergy combo Dymista - Pharma Times
FDA approves Meda allergy combo DymistaPharma TimesThe approval from the US Food and Drug Administration for Dymista (azelastine and fluticasone) is based on 'several studies involving more than 4000 patients', including one long-term safety study with more than 600 participants.
- FDA approves new treatment for seasonal allergic rhinitis - Clinical Advisor
FDA approves new treatment for seasonal allergic rhinitisClinical AdvisorThe FDA has approved azelastine HCI and fluticasone propionate nasal spray (Dymista, Meda) to treat seasonal allergic rhinitis.
- FDA Sends Letter to Meda Pharmaceuticals Over Astepro Telephone Script - PharmaLive.com (press release)
FDA Sends Letter to Meda Pharmaceuticals Over Astepro Telephone ScriptPharmaLive.
- Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year ... - MarketWatch (press release)
Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year .
|
| Copyright © www.drugsengine.com is an affiliate marketing website. Tous droits réservés. |